ECM
ABBV icon

Eisler Capital Management’s AbbVie ABBV Stock Holding History

Eisler Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$277K Sell
1,311
-2,399
-65% -$489K ﹤0.01% 698
2025
Q2 		$689K Buy
3,710
+3,604
+3,400% +$670K ﹤0.01% 665
2025
Q1 		$22.2K Sell
106
-20,019
-99% -$3.89M ﹤0.01% 886
2024
Q4 		$3.61M Buy
+20,125
New +$3.7M 0.02% 492

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eisler Capital Management's ABBV Position: Q3 2025 in Review

Eisler Capital Management reduced its AbbVie (ABBV) stake by 65% in Q3 2025, selling an estimated $489K and leaving 1,311 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #698.

Eisler Capital Management first reported a position in ABBV in Q4 2024 and has held it in 4 quarters since. The position peaked at $3.61M in Q4 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Eisler Capital Management held 1,311 shares of AbbVie worth $277K as of Q3 2025.
  • Eisler Capital Management sold 2,399 AbbVie shares in Q3 2025, an estimated $489K.
  • AbbVie made up ﹤0.01% of Eisler Capital Management's portfolio in Q3 2025, its #698 holding.
  • Eisler Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 4 quarters since.
  • Eisler Capital Management's AbbVie position peaked at $3.61M in Q4 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.